We are live on ! Find out more
MITO

Stealth BioTherapeutics Corp. ADS
MITO

Delisted

MITO was delisted on the 15th of November, 2022.

Back to rankings

13 hedge funds and large institutions have $1.46M invested in Stealth BioTherapeutics Corp. ADS in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

75% more capital invested

Capital invested by funds: $835K → $1.46M (+$625K)

30% more funds holding

Funds holding: 10 → 13 (+3)

Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$672K
2
Mercer Global Advisors
Mercer Global Advisors
Colorado
+$70.2K
3
VF
Virtu Financial
New York
+$62.2K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$38.3K
5
Citadel Advisors
Citadel Advisors
Florida
+$30.1K

Top Sellers

Rank Fund Capital Flow
1
PM
Prosight Management
Texas
-$346K
2
HF
HRT Financial
New York
-$23K
3
UBS Group
UBS Group
Switzerland
-$9.98K

MITO Hedge Fund Activity: Q4 2020 in Review

13 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q4 2020, worth a combined $1.46M — up 75% from $835K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MITO positions and 2 closed out — a net gain of 4 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $672K. The largest seller was Prosight Management, exiting entirely with an estimated $346K sold.

  • 13 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q4 2020, up from 10 in Q3 2020.
  • Funds reported $1.46M of Stealth BioTherapeutics Corp. ADS stock for Q4 2020, up 75% quarter-over-quarter.
  • 6 funds opened new Stealth BioTherapeutics Corp. ADS positions in Q4 2020 and 2 closed out, a net change of +4 holders.
  • The largest Stealth BioTherapeutics Corp. ADS buyer in Q4 2020 was Renaissance Technologies, an estimated $672K added.
  • The largest Stealth BioTherapeutics Corp. ADS seller in Q4 2020 was Prosight Management, an estimated $346K sold.

Based on aggregated 13F filings for Q4 2020.